Pelthos Therapeutics Inc.
PTHS
$25.38
$0.240.96%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.58M | -9.04M | -7.36M | -7.96M | -10.07M |
| Total Depreciation and Amortization | 1.14M | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 335.10K | 345.40K | 180.70K | 692.10K | 535.70K |
| Total Other Non-Cash Items | 6.30M | 1.58M | 1.63M | 1.44M | 4.12M |
| Change in Net Operating Assets | -1.20M | 5.18M | 1.12M | 35.00K | -71.00K |
| Cash from Operations | -17.01M | -1.93M | -4.43M | -5.79M | -5.48M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 2.76M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2.76M | -- | -- | -- | -- |
| Total Debt Issued | 539.20K | -426.10K | 786.20K | 536.20K | 865.00K |
| Total Debt Repaid | -845.00K | -200.00 | -200.00 | -215.00K | -215.00K |
| Issuance of Common Stock | 167.60K | 82.60K | 82.60K | 6.05M | 6.23M |
| Repurchase of Common Stock | -75.00K | -75.00K | -75.00K | -75.00K | -- |
| Issuance of Preferred Stock | 27.38M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 75.00K | 500.00 | 500.00 | -91.00K | -166.00K |
| Cash from Financing | 27.25M | -418.20K | 794.10K | 6.21M | 6.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.00M | -2.35M | -3.64M | 417.50K | 1.23M |